JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Predicted arterial oxygenation at commercial aircraft cabin altitudes.

INTRODUCTION: The degree of hypoxia manifested by airline passengers during flight is not well characterized. Statistical models to predict age-specific levels of Pao2 manifest at altitudes between sea level and 8000 ft (Pao2alt) are described.

METHODS: The relationship between age and Pao2 at sea level (Pao2sl) and the relationship between Pao2alt, and Pao2sl, Pco2 at sea level (Pco2sl), and pulmonary health status were investigated using linear regression techniques to analyze previously published data.

RESULTS: In persons with normal pulmonary health, the relationship between Pao2sl (mmHg) and age (yr) was Pao2sl = 105.9 - 0.44 * age (R2 = 0.582, MSE = 25.314); Pco2sl (38.1 +/- 2.8 mmHg) was not related to age over the range 18-75 yr. In persons with chronic obstructive lung disease (COPD), neither Pao2sl (78.2 +/- 11.3 mmHg) nor Pco2sl (40.5 +/- 5.7 mmHg) were related to age (77.0 +/- 9.0 yrs).The relationship between PaO2alt and Pao2sl, Pco2sl and altitude (ft) was: Pao2alt = 1.59 + 0.98 * Pao2sl + 0.0031 * Alt - 0.000061 * Pao2sl * Alt - 0.000065 * PCO(2)sl [corrected] * Alt + 0.000000092 * Alt2 (R2 = 0.932, MSE = 22.774).

DISCUSSION: Pao2sl declines with age in persons with normal pulmonary health; Pco2sl remains constant. Neither vary with age in persons with COPD. Pao2alt can be estimated with acceptable precision from knowledge of Pao2sl, Pco2sl, and altitude. These models predict a substantial proportion of older passengers will manifest a Pao2alt at 8000 ft below the threshold at which supplemental oxygen is recommended.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app